In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...

Gilead Sciences, Inc. GILD announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European ...

The global vaccine adjuvants market is anticipated to reach USD 0.96 billion by 2029 from USD 0.70 billion in 2024, with a ...

registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this ...

Global Biologics Market Outlook to 2031The global biologics market was valued at US$ 515.6 billion in 2022 and is projected ...

Antibody-drug conjugates (ADCs) represent a promising cancer treatment modality designed to deliver highly potent cytotoxic ...